The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation by unknown
Brief  Definitive Report 
The Efficiency  of Acute Infection  of CD4 + T  cells Is 
Markedly Enhanced  in the  Setting of Antigen-specific 
Immune Activation 
By Drew Weissman,  Tobias D. Barker,  and Anthony S. Fauci 
From the Laboratory of lmmunoregulation, National Institute of  Allergy and Infectious Diseases, 
National Institutes of Health, Bethesda, MD 20892 
Summary 
Human immunodeficiency virus (HIV) disease  is sub-Saharan Africa generally differs from that 
observed in the United States and other developed countries in that the risk of seroconversion 
after exposure is greater and the rate of disease progression to AIDS and death is faster. One 
theory that could in part explain this difference is the increased state of immune activation asso- 
ciated with a relatively high rate of parasite infestation and other infections among inhabitants 
of these regions. Using a model based on the cellular microenvironment of lymphoid organs, 
the role of exposure to HIV during a state of antigen-specific immune activation was investi- 
gated. Dendritic cells and CD4 + T  cells are the major cellular components of the paracortical 
region of  lymphoid tissue,  the primary site of HIV replication. We analyzed cocultures of HIV- 
pulsed dendritic cells that had matured in the presence of tetanus toxoid and CD4 + T  cells be- 
fore and after inducing an antigen-specific response by in vivo immunization with tetanus tox- 
oid.  During antigen-specific immune activation,  100 times less HIV was needed to initiate  a 
productive infection. These findings provide a model system to further delineate the relation- 
ship between immune activation and the propagation of HIV infection and suggest a mecha- 
nism for the epidemiologic observations of an increased ease of developing HIV infection and 
faster progression for HIV disease in geographic areas where immune activation is prevalent. 
C 
ellular  activation  is  an  important  component  of the 
pathogenesis of HIV disease (1,  2).  It has been dem- 
onstrated in in vitro experiments that propagation of HIV 
in culture depends to varying degrees on the state of activa- 
tion of the target cells (3-7). With in vivo correlates, mark- 
ers  of cellular  activation  have  been  demonstrated  to  be 
closely associated with the level of HIV disease activity (8-10). 
Furthermore, it has been observed that in sub-Saharan Af- 
rica, individuals have an increased risk of acquiring HIV in- 
fection  on  exposure  to  the  virus,  and  disease  progresses 
more rapidly after infection as  compared with individuals 
in developed countries  (11-13).  It has been proposed that 
these  differences can be explained,  at least in part, by the 
heightened level of activation of the immune system in Af- 
ricans,  which  is  related  to  the  chronically active immune 
responses to parasitic infestations and infection with other 
pathogenic microbes (13,  14). 
Recently, other lines of evidence have supported the as- 
sociation of immune activation and HIV pathogenesis.  In 
has been demonstrated that replication of HIV occurs pre- 
dominantly  in  the  activated population  of CD4 +  T  cells 
that are rapidly turning over and recently infected (15,  16). 
Other studies  have demonstrated  that in  the  spleen,  HIV 
replication occurs in T  cells in the white pulp that is driven 
to divide in an antigen-specific manner (17).  We and oth- 
ers  have  demonstrated  that  HIV  replication  occurs  pre- 
dominantly in the lymphoid tissues  throughout  the entire 
course of HIV disease  (18,  19).  Dendritic cell (DC)-T cell 
interactions have been shown to be important in the initia- 
tion and propagation of HIV infection (20-23).  In this re- 
gard, DC populate the paracortical regions of lymph nodes 
(24)  where they come into close proximity with CD4 + T 
cells. DC are the major APC to T  cells,  and in the process 
of an antigen-specific immune response DC-T cell interac- 
tion,  they result in T  cell activation (24).  In the setting of 
an HIV-infected lymph node, an ongoing antigen-specific 
response would be a favorable milieu for the initiation  or 
propagation of HIV infection. 
In the present study, we use an in vitro model system of 
presentation of antigen by DC to CD4 + T  cells in the pres- 
ence of HIV to directly address the question of the role of 
an ongoing antigen-specific immune response in the initia- 
tion and propagation of HIV infection; this system mimics 
the in vivo microenvironment of lymphoid tissue.  We im- 
munized healthy volunteers with tetanus toxoid, and 2 wk 
after immunization,  exposed their DC in vitro to  tetanus 
antigen  and  allowed  the  DC  to  present  the  antigen  to 
CD4 + T  cells in the presence of HIV. We found that up to 
100 times less virus was required to initiate HIV infection 
in  cultures from individuals  after immunization compared 
687  J. Exp. Med. ￿9  The Rockefeller University Press ￿9 0022-1007/96/02/687/06  $2.00 
Volume 183  February 1996 687-692 with before immunization, indicating the potential contri- 
bution of the cellular activation associated with an ongoing 
antigen-specific immune  response  to  the  pathogenesis  of 
HIV disease. 
Materials  and Methods 
Reagents.  RPMI  1640  (Biowittaker, Walkersville, MD) was 
supplemented  with  glutamine  (2  mM)  (Biofluids,  Rockville, 
MD), peniciUin-streptomycin (Biofluids),  Hepes (15 mM)  (Bio- 
fluids), and  10%  normal human  AB  + serum  (NHS)  (Advanced 
Biotechnologies, Inc.,  Columbia,  MD)  or  10%  FCS  (Hyclone 
Laboratories Inc., Logan, UT). No difference in the proliferation 
in autologous MLR.s between DC and CD4 + T cells or CD4 § T 
cells alone, or in the HIV infection assays was observed between 
NHS and this lot of FCS such that the two sera were used inter- 
changeably. 
DC Purification.  DC were purified (Fig. 1) either before or 2 
wk after tetanus toxoid immunization from leukopaks obtained 
from healthy volunteers under  an  Institutional Review Board- 
approved protocol.  PBMC  were  obtained by  Ficoll-Hypaque 
density gradient centrifugation. To  simulate an antigen-specific 
activated immune state, DC matured in the presence of antigen 
were prepared from PBMC by first depleting T  cells with 2-ami- 
noethylisothiouronium bromide-treated SRBC-T  cell rosetting 
as previously described (25). The DC precursors present in the T 
cell-depleted PBMC were cultured overnight in the presence of 
tetanus toxoid (Wyeth-Ayerst Laboratories, Marietta, PA), mumps 
antigen (Connaught Laboratories, Swiftwater, PA), or no antigen 
(control). The DC were then purified as described previously, us- 
ing metrizamide density gradient centrifugation and negative se- 
lection (20, 25). 
HIV Infection.  B  cells and CD4 + T  cells were purified from 
PBMC and SRBC-rosetted T  cells after overnight culture to al- 
low  dissociation of mature  DC  from T  cells  using  CD19  and 
CD4  magnetic beads  (Dynal,  Lake Success,  NY),  respectively. 
The beads were mixed with cells at a 3:1 ratio for 30 min on ice. 
Cells bound to beads were separated using a magnet and detached 
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Figure 1.  Protocol for the purification of DC that have matured in the 
presence of tetanus toxoid, mumps, or media control and coculture with 
CD4 § T cells for measurement of [3H]thymidine incorporation, cellular 
activation, and HIV infection. 
from the beads with the Detach-a-Bead product (Dynal). Mac- 
rophages were depleted on human Ig-coated plates (20). CD4 + T 
cells were 99% CD4 § and contained no CD3- HLA-DR,  + con- 
taminants. Purified populations of DC and B cells were incubated 
with decreasing multiplicities of infection (MOI) of HIVmn (Ad- 
vanced Biotechnologies, Inc.) for 1.5 h at 37~  followed by two 
washes to remove unbound virus. Experiments with HIV-pulsed 
DC  worked equally well with  primary isolates and  laboratory 
strains;  however, since primary viral isolates were obtained from 
PHA-stimulated T  cell blasts or monocyte-derived macrophages, 
which contained cytokines that could alter DC function, purified 
HIVnl  B was used. The HIV-pulsed ceils (5 ￿  103 cells/well) were 
mixed with autologous CD4 § T  cells (105 cells/well) in 96-well 
fiat-bottom microtitier plates  (Costar Corp.,  Cambridge, MA). 
Fresh medium was replenished twice weekly. Supernatants for re- 
verse transcriptase (R.T)  activity were removed every 2-3 d and 
frozen at  -70~  R.T activity was measured as described previ- 
ously (25). 
Measures of Cellular Proliferation and Activation.  Cocultures of DC 
or B cells and CD4 + T  cells (5  ￿  104) were performed in tripli- 
cate.  Cells were pulsed after 5  d with [3H]thymidine (0.5  ~Ci/ 
well)  (Amersham Corp.,  Arlington Heights,  IL)  for  16  h,  har- 
vested  (Tomtec  Harvester;  Wallac,  Gaithersburg,  MD),  and 
counted in a counter (Betaplate model 1205; Wallac). Expression 
of HLA-DR on CD4 § T  cells was analyzed by staining 3-d co- 
cultured (DC or B and/or CD4 + T) cells with anti-CD3-fluores- 
cein  and  anti-HLA-DR-PE  mAb  (Becton  Dickinson  &  Co., 
Mountain View, CA) and analyzing in a flow cytometer (Coulter 
Corp., Hialeah, FL). 
Statistical Analysis.  Values from triplicate cultures were aver- 
aged,  and  SEM  were  calculated using the  Excel  TM  (Microsoft, 
Redmond,  WA) software package. Typically, SE  errors ranged 
from 5 to 15%. 
Results 
The Effect of Tetanus  Toxoid Immunization  on Cellular Acti- 
vation and Proliferation in Cocultures  of CD4 + T  Cells and DC 
That  Had  Been  Matured  in  the  Presence of Tetanus  Antigen. 
It has been previously demonstrated that DC can bind HIV 
to their surface and induce infection in co-cultured autolo- 
gous CD4 + T  cells in the absence of added mitogen  (20). 
This infection can be modulated by exogenously added and 
endogenously produced cytokines and is dependent on ac- 
tivation  of the  CD4 +  T  cells  (20;  Weissman,  D.,  T.  D. 
Barker, and A. S. Fauci, unpublished observations). 
In individuals before tetanus immunization  (date of last 
tetanus shot, 2.5 to >10 yr), maturation of DC in the pres- 
ence  of tetanus  toxoid,  95  lymphocyte  flocculation  unit 
(LRS)/ml (60  Ixg/ml), did not enhance the proliferation of 
CD4 +  T  cells cocultured with these DC  when  compared 
with CD4 + T  cells cocultured with DC that were matured 
in the presence of mumps antigen or media (control)  (Fig. 
2  A).  However,  all DC-T  cell cocultures showed  signifi- 
cant  levels  of proliferation  compared  with  B  cell-T  cell 
cocultures demonstrating an active autologous MLR. Anal- 
ysis  of proliferation  in  tetanus  toxoid--stimulated unfrac- 
tionated  PBMC  also  demonstrated  minimal  stimulation, 
less  than  twofold  above  control  (data  not  shown)  before 
tetanus immunization.  It has been demonstrated that 2 wk 
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Figure 2.  Maturation of DC in the pres- 
ence of tetanus toxoid does not  increase 
proliferation in CD4 + T cells in preimmu- 
nized  individuals but  markedly increases 
proliferation 2 wk after tetanus immuniza- 
tion. (A) Before tetanus immunization,  DC 
were matured in the  presence of tetanus 
toxoid, 95 LfU/ml, and purified as described 
in Fig. 1 and Materials and Methods. When 
these cells were cocultured with CD4  + T 
cells, they induced a substantial  autologous 
MLIL but  did  not  increase proliferation 
above that induced by DC matured in the 
presence of no antigen or mumps antigen. 
(B)  2 wk after tetanus immunization, DC 
matured in the presence of tetanus toxoid 
induced a significant  increase in CD4  + T 
cell proliferation compared with  that in- 
duced by DC  matured in the presence of 
mumps antigen or no antigen. Decreasing 
numbers of DC or B cells were added to 
50,000  CD4  +  T  cells and  pulsed with 
[3H]thymidine  for 16 h on day 5, harvested, 
and counted. DC or B cells alone did not 
proliferate above background.  CD4  + T cells 
typically incorporated 150  cpm. Data are 
from one individual  that is representative  of 
seven (A) and three (B) others tested. 
after tetanus immunization, there is a peak of tetanus-spe- 
cific T  cells in PBMC  (26).  We chose  this time point to 
obtain a population ofCD4 + T  cells that were enriched for 
tetanus-specific cells capable of responding to  an in vitro 
challenge with tetanus (26).  DC,  obtained 2  wk after im- 
munization and matured in the presence of tetanus toxoid, 
induced a significant increase in proliferation of cocultured 
CD4 +  T  cells  obtained at  the  same  time compared with 
DC  that were matured in the presence of mumps antigen 
or control (Fig. 2 B). 
Activation ofCD4 + T  cells by DC was measured by de- 
termining the expression of HLA-DR. on T  cells after 3  d 
of coculture. The in vitro maturation of DC in the pres- 
ence of tetanus toxoid in subjects before immunization did 
not  increase  the  level  of HLA-DR  expression  (data  not 
shown). In cells obtained 2 wk after tetanus immunization, 
the DC that were matured in the presence of tetanus tox- 
oid  induced  an  increase  in  the  percentage  of  activated 
CD4 + T  cells.  Variability among donors in the percentage 
of CD4 +  T  cells activated in coculture with DC was ob- 
served (ranging from 10 to 38% for control DC); however, 
in all cases, DC obtained 2 wk after immunization  and ma- 
tured in the presence of tetanus toxoid induced a 50-75% 
increase in the  expression of HLA-DR on CD4  +  T  cells 
(data not shown). 
The Effect  of Immunization  on the Infectability  with HIV of 
CD4 + T  Cells  Cocuhured with DC That  Were Matured in the 
Presence of Tetanus Toxoid.  It has previously been demon- 
strated that two populations of DC were present after puri- 
fication of overnight-cultured PBMC. One population was 
DC derived from DC precursors, and the second popula- 
tion was de novo mature DC that were bound to T  cells 
and released during overnight culture (25).  These mature 
DC,  which are  depleted by SRBC  rosetting before over- 
night culture because of their conjugation with CD4  +  T 
cells, were necessary for efficient induction of infection in 
autologous, unstimulated CD4 +  T  cells  (20).  In the  next 
set of experiments, no mature DC were added, which re- 
sulted  in  no  infection in  the  HIV-pulsed  control  DC- 
CD4 + T  cell cocultures. 
Before tetanus immunization,  the pulsing of DC that had 
matured in the presence of tetanus with decreasing MOI of 
HIV  followed  by  culturing with  unstimulated CD4  +  T 
cells and measurement of RT activity demonstrated no en- 
hancement of infection compared with control DC (Fig. 3 
A). 2 wk after immunization,  no infection was observed for 
the control-treated DC, even when pulsed with a MOI = 
0.1  (Fig. 3 B).  DC matured in the presence of tetanus tox- 
oid-induced efficient infection when pulsed with as little as 
0.001  infectious units of virus per DC  (Fig. 3  D).  B  cells 
exposed to tetanus antigen 2  wk after immunization were 
ineffective in transferring infection to  CD4 +  T  cells  (data 
not shown). DC matured in the presence of mumps anti- 
gen  also  induced no  infection 2  wk  after  immunization 
(Fig. 3,  B-D).  Similar results were obtained when tetanus 
was added to cocultures of DC and CD4 + T  cells, although 
less sensitivity and greater variability were noted. 
Similar experiments were  performed with much lower 
concentrations of tetanus, 1 Lt-U/ml (0.12 mg/ml), and the 
addition of small numbers of mature DC, which resulted in 
infection in the  control-treated DC-CD4 +  T  cell cocul- 
tures. After immunization, 25 times less HIV was required 
to  initiate a productive infection in cocultures of tetanus- 
matured DC  and CD4 +  T  cells  (data  not shown).  Thus, 
HIV-pulsed DC that are in the process of interacting with 
and presenting antigen to antigen-specific CD4 + T  cells are 
much more efficient at inducing a productive infection in 
the CD4 + T  cells. 
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Figure 3.  100 times less HIV is required to induce a productive infec- 
tion in cocultures of DC matured in the presence of tetanus toxoid and 
CD4 + T cells obtained 2 wk after immunization compared with similar 
cultures before immunization. (A) Before tetanus immunization, no in- 
fection was observed in cocultures of HIV-pulsed DC matured in the 
presence or absence of tetanus toxoid and CD4 + T cells. (/3) 2 wk after 
immunization, DC matured in the presence of mumps antigen or media 
(control) induced no infection even when  pulsed with a MOI =  0.1, 
whereas DC matured in the presence of tetanus toxoid induced produc- 
tive infection when pulsed with a MOI of 0.001. All cocultures were run 
in culture triplicates. Data are representative of three (/t) and four (B-D) 
experiments. 
Discussion 
Using a protocol of in vivo immunization with a  com- 
mon  recall  antigen  (tetanus  toxoid)  and  a  physiologically 
based in vitro model system of DC presentation of HIV to 
CD4 §  T  cells, this study has  demonstrated that,  after im- 
munization, up  to  100  times less HIV  compared with be- 
fore immunization is required to be pulsed onto DC to al- 
low them to initiate a productive infection in CD4 + T  cells 
when  the DC  are in the  process of presenting antigen to 
these  cells.  These  studies  directly address the  question  of 
the potential pathophysiologic role of cellular activation as- 
sociated with ongoing antigen-specific responses in the ini- 
tiation and propagation of HIV infection. 
DC-CD4 +  T  cell interactions have been proposed as a 
model for the initiation and propagation of HIV infection 
(20-23).  The paracortical or T  cell region of lymphoid or- 
gans is a major site of HIV replication (19; Weissman, D., 
and  A.  S.  Fauci,  unpublished  observations).  DC  are  the 
most  eflScient APC  to  CD4 +  T  cells  and  are  present  in 
abundance  in  the  paracortical region  of the  lymph  node 
(24).  Presentation of any antigen by DC  to  CD4 +  T  cells 
provides a  potentially important source  of cellular activa- 
tion to CD4*  T  cells, which, when in proximity to infec- 
tious virus favors eflficient virus replication. 
The role of cellular activation in the initiation and prop- 
agation of HIV infection of CD4 + T  cells in vitro has been 
firmly established (3-7). A  similar in vivo phenomenon has 
been suggested in reports of an increase in HIV replication 
in HIV-infected humans  or chimps who were immunized 
with specific antigen or infected with pathogenic microbes 
(27-30).  In addition, it has been reported that immune ac- 
tivation  at  the  time  of acute  infection  of monkeys  with 
simian immunodeficiency virus led to an accelerated course 
of disease (31).  Furthermore,  recent studies have indicated 
that the cellular activation associated with the rapid CD4 + 
T  cell turnover associated with high levels of virus replica- 
tion (15, 16) and the antigen-specific activation ofCD4 + T 
cells in the splenic white pulp (17) are important contribu- 
tors  to  the  high  degree  of virus  production  observed  in 
HIV infection. Parallel with these findings are the observa- 
tions  that  treatment  of  HIV-infected  individuals  with 
agents that might decrease cellular activation, under certain 
circumstances,  could  have  a  transient  beneficial effect  on 
surrogate markers of HIV disease (32, 33). 
It  has  recently  been  hypothesized  that  the  observed 
higher rate  of HIV disease progression as well as suscepti- 
bility to  infection  on  exposure  to  HIV  in  individuals in 
sub-Saharan  Africa might  be  due,  at  least in  part,  to  the 
chronic  and  persistent  immune  activation associated with 
the  ongoing immune  response  to  parasitic infestation and 
other infections that are common among individuals living 
in  this  region  (13,  14).  This  study provides  experimental 
support  for  this  hypothesis  and  should  provide  a  useful 
model to  further  delineate the  precise mechanisms  of the 
enhancement  of HIV  infection  associated  with  antigen- 
specific immune responses. Furthermore, it may contribute 
to the development of public health strategies for the sup- 
pression and elimination of microbes that induce these an- 
tigen-specific immune responses. 
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